CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview with a focus on its intellectual property estate at the 19th Annual Piper Jaffray Health Care Conference on Wednesday, November 28, 2007, at 8:00 a.m. ET at The Pierre New York in New York City.
